|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Murali R, Soslow RA and Weigelt B:
Classification of endometrial carcinoma: More than two types.
Lancet Oncol. 15:e268–e278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Creasman WT, Odicino F, Maisonneuve P,
Quinn MA, Beller U, Benedet JL, Heintz AP, Ngan HY and Pecorelli S:
Carcinoma of the corpus uteri. FIGO 26th Annual report on the
results of treatment in gynecological cancer. Int J Gynaecol
Obstet. 95 (Suppl 1):S105–S143. 2006. View Article : Google Scholar
|
|
5
|
Colombo N, Creutzberg C, Amant F, Bosse T,
González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza
MR, et al: ESMO-ESGO-ESTRO consensus conference on endometrial
cancer: Diagnosis, treatment and follow-up. Radiother Oncol.
117:559–581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Morice P, Leary A, Creutzberg C,
Abu-Rustum N and Darai E: Endometrial cancer. Lancet.
387:1094–1108. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zang Y, Dong M, Zhang K, Tian W, Wang Y
and Xue F: Bioinformatics analysis of key differentially expressed
genes in well and poorly differentiated endometrial carcinoma. Mol
Med Rep. 18:467–476. 2018.PubMed/NCBI
|
|
8
|
Kaloglu S, Guraslan H, Tekirdag AI,
Dagdeviren H and Kaya C: Relation of preoperative thrombocytosis
between tumor stage and grade in patients with endometrial cancer.
Eurasian J Med. 46:164–168. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kong A, Johnson N, Kitchener HC and Lawrie
TA: Adjuvant radiotherapy for stage I endometrial cancer: An
updated Cochrane systematic review and meta-analysis. J Natl Cancer
Inst. 104:1625–1634. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Susumu N, Sagae S, Udagawa Y, Niwa K,
Kuramoto H, Satoh S and Kudo R; Japanese Gynecologic Oncology
Group, : Randomized phase III trial of pelvic radiotherapy versus
cisplatin-based combined chemotherapy in patients with
intermediate- and high-risk endometrial cancer: A Japanese
Gynecologic Oncology Group study. Gynecol Oncol. 108:226–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bradford LS, Rauh-Hain JA, Schorge J,
Birrer MJ and Dizon DS: Advances in the management of recurrent
endometrial cancer. Am J Clin Oncol. 38:206–212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsoref D, Welch S, Lau S, Biagi J, Tonkin
K, Martin LA, Ellard S, Ghatage P, Elit L, Mackay HJ, et al: Phase
II study of oral ridaforolimus in women with recurrent or
metastatic endometrial cancer. Gynecol Oncol. 135:184–189. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oza AM, Pignata S, Poveda A, McCormack M,
Clamp A, Schwartz B, Cheng J, Li X, Campbell K, Dodion P and
Haluska FG: Randomized phase II trial of ridaforolimus in advanced
endometrial carcinoma. J Clin Oncol. 33:3576–3582. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matulonis U, Vergote I, Backes F, Martin
LP, McMeekin S, Birrer M, Campana F, Xu Y, Egile C and Ghamande S:
Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147)
in patients with advanced or recurrent endometrial carcinoma.
Gynecol Oncol. 136:246–253. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Powell MA, Sill MW, Goodfellow PJ,
Benbrook DM, Lankes HA, Leslie KK, Jeske Y, Mannel RS, Spillman MA,
Lee PS, et al: A phase II trial of brivanib in recurrent or
persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology
Group Study. Gynecol Oncol. 135:38–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee PS and Secord AA: Targeting molecular
pathways in endometrial cancer: A focus on the FGFR pathway. Cancer
Treat Rev. 40:507–512. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Forster MD, Dedes KJ, Sandhu S, Frentzas
S, Kristeleit R, Ashworth A, Poole CJ, Weigelt B, Kaye SB and
Molife LR: Treatment with olaparib in a patient with PTEN-deficient
endometrioid endometrial cancer. Nat Rev Clin Oncol. 8:302–306.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Howitt BE, Shukla SA, Sholl LM,
Ritterhouse LL, Watkins JC, Rodig S, Stover E, Strickland KC,
D'Andrea AD, Wu CJ, et al: Association of polymerase e-Mutated and
microsatellite-instable endometrial cancers with neoantigen load,
number of tumor-infiltrating lymphocytes, and expression of PD-1
and PD-L1. JAMA Oncol. 1:1319–1323. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Duran-Sanchon S, Moreno L, Augé JM,
Serra-Burriel M, Cuatrecasas M, Moreira L, Martín A, Serradesanferm
A, Pozo À, Costa R, et al: Identification and validation of
microRNA profiles in fecal samples for detection of colorectal
cancer. Gastroenterology. 158:947–957.e4. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Polano M, Chierici M, Dal Bo M, Gentilini
D, Cintio FD, Baboci L, GibbsD L, Furlanello C and Toffoli G: A
Pan-cancer approach to predict responsiveness to immune checkpoint
inhibitors by machine learning. Cancers (Basel). 11:15622019.
View Article : Google Scholar
|
|
21
|
Zhang K, Li H, Yan Y, Zang Y, Li K, Wang Y
and Xue F: Identification of key genes and pathways between type I
and type II endometrial cancer using bioinformatics analysis. Oncol
Lett. 18:2464–2476. 2019.PubMed/NCBI
|
|
22
|
Chou WC, Cheng AL, Brotto M and Chuang CY:
Visual gene-network analysis reveals the cancer gene co-expression
in human endometrial cancer. BMC Genomics. 15:3002014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huo X, Sun H, Liu Q, Ma X, Peng P, Yu M,
Zhang Y, Cao D and Shen K: Clinical and expression significance of
AKT1 by Co-expression network analysis in endometrial cancer. Front
Oncol. 9:11472019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu Y, Nan F, Lu K and Wang Y, Liu Y, Wei
S, Wu R and Wang Y: Identification of key genes in endometrioid
endometrial adenocarcinoma via TCGA database. Cancer Biomark.
21:11–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu J, Zhou S, Li S, Jiang Y, Wan Y, Ma X
and Cheng W: Eleven genes associated with progression and prognosis
of endometrial cancer (EC) identified by comprehensive
bioinformatics analysis. Cancer Cell Int. 19:1362019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu L, Lin J and He H: Identification of
potential crucial genes associated with the pathogenesis and
prognosis of endometrial cancer. Front Genet. 10:3732019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen L, Yuan L, Qian K, Qian G, Zhu Y, Wu
CL, Dan HC, Xiao Y and Wang X: Identification of biomarkers
associated with pathological stage and prognosis of clear cell
renal cell carcinoma by Co-expression network analysis. Front
Physiol. 9:3992018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo X, Xiao H, Guo S, Dong L and Chen J:
Identification of breast cancer mechanism based on weighted gene
coexpression network analysis. Cancer Gene Ther. 24:333–341. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou XG, Huang XL, Liang SY, Tang SM, Wu
SK, Huang TT, Mo ZN and Wang QY: Identifying miRNA and gene modules
of colon cancer associated with pathological stage by weighted gene
Co-expression network analysis. Onco Targets Ther. 11:2815–2830.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Day RS, McDade KK, Chandran UR, Lisovich
A, Conrads TP, Hood BL, Kolli VS, Kirchner D, Litzi T and Maxwell
GL: Identifier mapping performance for integrating transcriptomics
and proteomics experimental results. BMC Bioinformatics.
12:2132011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kharma B, Baba T, Matsumura N, Kang HS,
Hamanishi J, Murakami R, McConechy MM, Leung S, Yamaguchi K, Hosoe
Y, et al: STAT1 drives tumor progression in serous papillary
endometrial cancer. Cancer Res. 74:6519–6530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hermyt E, Zmarzly N, Grabarek B,
Kruszniewska-Rajs C, Gola J, Jęda-Golonka A, Szczepanek K, Mazurek
U and Witek A: Interplay between miRNAs and Genes Associated with
Cell Proliferation in Endometrial Cancer. Int J Mol Sci.
20:60112019. View Article : Google Scholar
|
|
34
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: Affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stafford P: Methods in microarray
normalization. CRC Press. (Boca Raton). 2008. View Article : Google Scholar
|
|
36
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang B and Horvath S: A general framework
for weighted gene Co-expression network analysis. Stat Appl Genet
Mol Biol. 4:Article 17. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yip AM and Horvath S: Gene network
interconnectedness and the generalized topological overlap measure.
BMC Bioinformatics. 8:222007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ravasz E, Somera AL, Mongru DA, Oltvai ZN
and Barabási AL: Hierarchical organization of modularity in
metabolic networks. Science. 297:1551–1555. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu G, Wang LG, Han Y and He QY:
clusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fabregat A, Sidiropoulos K, Viteri G,
Forner O, Marin-Garcia P, Arnau V, D'Eustachio P, Stein L and
Hermjakob H: Reactome pathway analysis: A high-performance
in-memory approach. BMC Bioinformatics. 18:1422017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jupe S, Ray K, Roca CD, Varusai T,
Shamovsky V, Stein L, D'Eustachio P and Hermjakob H: Interleukins
and their signaling pathways in the Reactome biological pathway
database. J Allergy Clin Immunol. 141:1411–1416. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47:D607–D613. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Killcoyne S, Carter GW, Smith J and Boyle
J: Cytoscape: A community -based framework for network modeling.
Methods Mol Biol. 563:219–239. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: CytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Uhlén M, Fagerberg L, Hallström BM,
Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C,
Sjöstedt E, Asplund A, et al: Proteomics. Tissue-based map of the
human proteome. Science. 347:12604192015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li C: Doubly robust weighted log-rank
tests and Renyi-type tests under non-random treatment assignment
and dependent censoring. Stat Methods Med Res. 28:2649–2664. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen X, Thiaville MM, Chen L, Stoeck A,
Xuan J, Gao M, Shih IeM and Wang TL: Defining NOTCH3 target genes
in ovarian cancer. Cancer Res. 72:2294–2303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Devis L, Moiola CP, Masia N,
Martinez-Garcia E, Santacana M, Stirbat TV, Brochard-Wyart F,
García Á, Alameda F, Cabrera S, et al: Activated leukocyte cell
adhesion molecule (ALCAM) is a marker of recurrence and promotes
cell migration, invasion, and metastasis in early-stage
endometrioid endometrial cancer. J Pathol. 241:475–487. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Klat J, Mladenka A, Dvorackova J, Bajsova
S and Simetka O: L1CAM as a negative prognostic factor in
endometrioid endometrial adenocarcinoma FIGO Stage IA-IB.
Anticancer Res. 39:421–424. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Shichiri M, Yoshinaga K, Hisatomi H,
Sugihara K and Hirata Y: Genetic and epigenetic inactivation of
mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to
survival. Cancer Res. 62:13–17. 2002.PubMed/NCBI
|
|
53
|
Dong S, Huang F, Zhang H and Chen Q:
Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues
predicts poor survival in pancreatic ductal adenocarcinoma. Biosci
Rep. 39:BSR201823062019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ando K, Kakeji Y, Kitao H, Iimori M, Zhao
Y, Yoshida R, Oki E, Yoshinaga K, Matumoto T, Morita M, et al: High
expression of BUBR1 is one of the factors for inducing DNA
aneuploidy and progression in gastric cancer. Cancer Sci.
101:639–645. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yamamoto Y, Matsuyama H, Chochi Y, Okuda
M, Kawauchi S, Inoue R, Furuya T, Oga A, Naito K and Sasaki K:
Overexpression of BUBR1 is associated with chromosomal instability
in bladder cancer. Cancer Genet Cytogenet. 174:42–47. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Liu AW, Cai J, Zhao XL, Xu AM, Fu HQ, Nian
H and Zhang SH: The clinicopathological significance of BUBR1
overexpression in hepatocellular carcinoma. J Clin Pathol.
62:1003–1008. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bang LG, Dasari VR, Kim D and Gogoi RP:
Differential gene expression induced by Verteporfin in endometrial
cancer cells. Sci Rep. 9:38392019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chang DZ, Ma Y, Ji B, Liu Y, Hwu P,
Abbruzzese JL, Logsdon C and Wang H: Increased CDC20 expression is
associated with pancreatic ductal adenocarcinoma differentiation
and progression. J Hematol Oncol. 5:152012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon
DS, Wersto RP, Tully E, Wilsbach K and Gabrielson E: Increased
expression of mitotic checkpoint genes in breast cancer cells with
chromosomal instability. Clin Cancer Res. 12:405–410. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wu WJ, Hu KS, Wang DS, Zeng ZL, Zhang DS,
Chen DL, Bai L and Xu RH: CDC20 overexpression predicts a poor
prognosis for patients with colorectal cancer. J Transl Med.
11:1422013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Huo X, Sun H, Cao D, Yang J, Peng P, Yu M
and Shen K: Identification of prognosis markers for endometrial
cancer by integrated analysis of DNA methylation and RNA-Seq data.
Sci Rep. 9:99242019. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Egloff AM, Vella LA and Finn OJ: Cyclin B1
and other cyclins as tumor antigens in immunosurveillance and
immunotherapy of cancer. Cancer Res. 66:6–9. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gu J, Liu X, Li J and He Y: MicroRNA-144
inhibits cell proliferation, migration and invasion in human
hepatocellular carcinoma by targeting CCNB1. Cancer Cell Int.
19:152019. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Eberlein A, Takasuga A, Setoguchi K, Pfuhl
R, Flisikowski K, Fries R, Klopp N, Fürbass R, Weikard R and Kühn
C: Dissection of genetic factors modulating fetal growth in cattle
indicates a substantial role of the non-SMC condensin I complex,
subunit G (NCAPG) gene. Genetics. 183:951–964. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Zhang Q, Su R, Shan C, Gao C and Wu P:
Non-SMC condensin I Complex, Subunit G (NCAPG) is a novel mitotic
gene required for hepatocellular cancer cell proliferation and
migration. Oncol Res. 26:269–276. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Branchi V, Garcia SA, Radhakrishnan P,
Győrffy B, Hissa B, Schneider M, Reißfelder C and Schölch S:
Prognostic value of DLGAP5 in colorectal cancer. Int J Colorectal
Dis. 34:1455–1465. 2019. View Article : Google Scholar : PubMed/NCBI
|
